Cathepsin inhibitors as potent inhibitors against SARS-CoV-2 main protease. In silico molecular screening and toxicity prediction

Cathepsin inhibitors as potent inhibitors against SARS-CoV-2 main protease. In silico molecular screening and toxicity prediction

Since the emergence of the newly identified Coronavirus SARS-CoV-2, no targeted therapeutic agents for COVID-19 treatment are available, and effective treatment options remain very limited. Successful crystallization of the SARS-CoV-2 main protease (Mpro, PDB-ID 6LU7) made possible the research on f...

Full description

Bibliographic Details
Main Authors: O. Sekiou, W. Kherfane, M. Boumendjel, H. Cheniti, A. Benselhoub, S. Bellucci
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2023-02-01
Series:The Ukrainian Biochemical Journal
Subjects:
6lu7
cathepsin inhibitors
covid19
in silico prediction
main protease
molecular docking
sars-cov-2
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2023/04/Sekiou_95_1.pdf

Internet

http://ukrbiochemjournal.org/wp-content/uploads/2023/04/Sekiou_95_1.pdf

Similar Items